These immune cells can play complementary roles in tumor clearance, where M1 macrophages and DCs can promote the priming of CD8+ T cells and NK cells with antigen presentation and proinflammatory responses, and CD8+ T cells and NK cells directly target and kill cancer cells in an antigen-specific and nonspecific manner, respectively [38]. Here, CD8A is linked to cancer.